Literature DB >> 21893493

The epidemiology of thyroid disease.

Mark P J Vanderpump1.   

Abstract

INTRODUCTION: Thyroid disorders are prevalent and their manifestations are determined by the dietary iodine availability. SOURCES OF DATA: Data from screening large population samples from USA and Europe. AREAS OF AGREEMENT: The most common cause of thyroid disorders worldwide is iodine deficiency, leading to goitre formation and hypothyroidism. In iodine-replete areas, most persons with thyroid disorders have autoimmune disease. AREAS OF CONTROVERSY: Definition of thyroid disorders, selection criteria used, influence of age and sex, environmental factors and the different techniques used for assessment of thyroid function. GROWING POINTS: Increasing incidence of well-differentiated thyroid cancer. Environmental iodine influences the epidemiology of non-malignant thyroid disease. AREAS TIMELY FOR DEVELOPING RESEARCH: Iodine supplementation of populations with mild-to-moderate iodine deficiency. An evidence-based strategy for the risk stratification, treatment and follow-up of benign nodular thyroid disease. Is there any benefit in screening adults for thyroid dysfunction?

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893493     DOI: 10.1093/bmb/ldr030

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  212 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 2.  Influence of maternal thyroid hormones during gestation on fetal brain development.

Authors:  N K Moog; S Entringer; C Heim; P D Wadhwa; N Kathmann; C Buss
Journal:  Neuroscience       Date:  2015-10-03       Impact factor: 3.590

3.  Fluoridation and hypothyroidism--a commentary on Peckham et al.

Authors:  M Foley
Journal:  Br Dent J       Date:  2015-11-13       Impact factor: 1.626

4.  Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests.

Authors:  Michael T Sheehan; Suhail A R Doi
Journal:  Clin Med Res       Date:  2016-02-10

5.  Hypothyroidism reduces mammary tumor progression via Β-catenin-activated intrinsic apoptotic pathway in rats.

Authors:  C M López Fontana; L E Zyla; F E Santiano; C V Sasso; F D Cuello-Carrión; V Pistone Creydt; M A Fanelli; R W Carón
Journal:  Histochem Cell Biol       Date:  2017-02-13       Impact factor: 4.304

6.  Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice.

Authors:  Gianluca Trifirò; Fabrizio Parrino; Janet Sultana; Francesco Giorgianni; Carmen Ferrajolo; Elisa Bianchini; Gerardo Medea; Salvatore Benvenga; Iacopo Cricelli; Claudio Cricelli; Francesco Lapi
Journal:  Clin Drug Investig       Date:  2015-03       Impact factor: 2.859

7.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

8.  Value of strain-ratio on thyroid real-time sonoelastography.

Authors:  Manlio Guazzaroni; Alessio Spinelli; Irene Coco; Costantino Del Giudice; Valentina Girardi; Giovanni Simonetti
Journal:  Radiol Med       Date:  2014-01-10       Impact factor: 3.469

9.  Acoustic radiation force impulse elastography for differentiation of benign and malignant thyroid nodules with concurrent Hashimoto's thyroiditis.

Authors:  Bo-Ji Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu; Dan-Dan Li; Xiao-Wan Bo; Xiao-Long Li; Le-Hang Guo; Xiao-Hong Xu; Shen Qu
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

10.  Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Giuseppe Vita; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.